Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry
ISSN: 0975-413X
Abstract
Design, synthesis, docking and evolution of fused imidazoles as antiinflammatory and antibacterial agents
Author(s): Galal A. M. Nawwar, Nabil M. Grant, Randa H. Swellem and Samia A. M. ElseginyNew benzimidazole and imidzopyridine derivatives were designed and synthesized from their corresponding oximes II. The newly synthesized compounds were investigated in vivo for their anti-inflammatory and analgesic activities. Some of the new compounds (IVc, IVf, IVi) showed reasonable anti-inflammatory and analgesic activity in experimental rats in comparing to indomethacin and Diclofenac Na, as reference drugs Moreover, some of the newly synthesized compounds tested as antimicrobial agents, IVh exhibited potent antimicrobial activities with low MIC in comparing with Cefoperazone and Fluconazole as reference drugs Docking studies was carried out for derivatives of highest anti-inflammatory activity into the COX-2 binding site. Designed compounds IVc,IVf,IVi revealed a similar binding mode to COX-2 inhibitor.
Select your language of interest to view the total content in your interested language
Google Scholar citation report
Citations : 15261
Der Pharma Chemica received 15261 citations as per Google Scholar report
Der Pharma Chemica peer review process verified at publons
